IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,000 | +1200.0% | 1,813 | +602.7% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 258 | +11.2% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 232 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 232 | -16.8% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 279 | -26.2% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 378 | -50.3% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 760 | +34.0% | 0.00% | – |
| Q4 2019 | $3,000 | +200.0% | 567 | +15.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 491 | +105.4% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 239 | -20.6% | 0.00% | – |
| Q1 2019 | $1,000 | – | 301 | +3244.4% | 0.00% | – |
| Q3 2018 | $0 | – | 9 | -35.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 14 | -98.6% | 0.00% | – |
| Q4 2016 | $2,000,000 | +66566.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | – | 1,000 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2014 | $32,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |